Standard breast tumor classification has long relied on morphological and anatomical criteria such as tumor size and extension (TNM staging), histopathological features (tumor grade) and expression of protein markers such as the estrogen receptor (ER), progesterone receptor (PR) and the human epidermal growth factor receptor 2 (HER2) oncogene [1,2]. Here, ERBB2 is linked to neoplasm.